Genome-wide profiling revealed that UCRs have distinct signatures in human leukemias and carcinomas.

Here, additional observations reinforced the hypothesis that Ikaros expression may be deregulated in human leukemias.

Human leukemias provide additional information: because of the blockade in differentiation, leukemias represent an equivalent of a particular stage of human hematopoietic hierarchy.